跳至主要内容
临床试验/IRCT20131125015536N13
IRCT20131125015536N13招募中未知

Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19

Tehran University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 70 years(—)
性别
All

入选标准

  • Confirmation of Covid-19 by positive PCR test or lung scan
  • Admission to hospital Corona wards other than ICU
  • Filling out the informed consent form by the patient or the patient's first-degree relatives

排除标准

  • Chemotherapy
  • People living with HIV
  • History of heart attack and stroke in the last 3 months
  • History of CABG
  • Dialysis patients
  • Transplantation of body organs
  • Pregnancy and lactation
  • People with BMI above 40
  • Known food allergies
  • Having any liver failure
  • Malignancies
  • Uncontrolled Diabetes (A1c>7.5)

研究者

相似试验